DocMorris AG's (VTX:DOCM) Subdued P/S Might Signal An Opportunity
Oct 25
Have your own idea? Try our Stock Screener
Swiss (SMI) Drug Retail Industry Analysis
UpdatedNov 28, 2024
DataAggregated Company Financials
Companies1
- 7D-3.6%
- 3M-21.9%
- 1Y-49.2%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 4.3%, driven by declines from every company within the industry. Overall the industry is down 46% in 12 months. Looking forward, earnings are forecast to grow by 57% annually.
Industry Valuation and Performance
Has the Swiss Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 28 Nov 2024 | CHF 382.5m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -3.9x | 0.4x |
| Sat, 26 Oct 2024 | CHF 467.6m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -4.8x | 0.5x |
| Mon, 23 Sep 2024 | CHF 427.2m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -4.4x | 0.4x |
| Wed, 21 Aug 2024 | CHF 539.0m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -4.6x | 0.6x |
| Fri, 19 Jul 2024 | CHF 588.0m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -5x | 0.6x |
| Sun, 16 Jun 2024 | CHF 753.0m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -6.4x | 0.8x |
| Tue, 14 May 2024 | CHF 912.5m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -7.8x | 0.9x |
| Thu, 11 Apr 2024 | CHF 1.0b | CHF 969.5m | -CHF 117,565,000.00 | n/a | -8.5x | 1x |
| Sat, 09 Mar 2024 | CHF 853.8m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -5.9x | 0.5x |
| Mon, 05 Feb 2024 | CHF 934.3m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -6.4x | 0.6x |
| Wed, 03 Jan 2024 | CHF 867.3m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -5.9x | 0.6x |
| Fri, 01 Dec 2023 | CHF 733.2m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -5x | 0.5x |
| Sun, 29 Oct 2023 | CHF 437.7m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -3x | 0.3x |
| Tue, 26 Sep 2023 | CHF 610.9m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -4.2x | 0.4x |
| Thu, 24 Aug 2023 | CHF 741.5m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -5.1x | 0.5x |
| Sat, 22 Jul 2023 | CHF 590.8m | CHF 1.6b | -CHF 171,115,000.00 | n/a | -3.5x | 0.4x |
| Mon, 19 Jun 2023 | CHF 454.7m | CHF 1.6b | -CHF 171,115,000.00 | n/a | -2.7x | 0.3x |
| Wed, 17 May 2023 | CHF 400.4m | CHF 1.6b | -CHF 171,115,000.00 | n/a | -2.3x | 0.2x |
| Fri, 14 Apr 2023 | CHF 455.1m | CHF 1.6b | -CHF 171,115,000.00 | n/a | -2.7x | 0.3x |
| Sun, 12 Mar 2023 | CHF 578.7m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -2.5x | 0.3x |
| Tue, 07 Feb 2023 | CHF 660.4m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -2.8x | 0.4x |
| Thu, 05 Jan 2023 | CHF 388.8m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -1.7x | 0.2x |
| Sat, 03 Dec 2022 | CHF 386.1m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -1.6x | 0.2x |
| Mon, 31 Oct 2022 | CHF 328.7m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -1.4x | 0.2x |
| Wed, 28 Sep 2022 | CHF 378.2m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -1.6x | 0.2x |
| Fri, 26 Aug 2022 | CHF 482.3m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -2.1x | 0.3x |
| Sun, 24 Jul 2022 | CHF 682.4m | CHF 1.7b | -CHF 225,735,000.00 | n/a | -3x | 0.4x |
| Tue, 21 Jun 2022 | CHF 893.9m | CHF 1.7b | -CHF 225,735,000.00 | n/a | -4x | 0.5x |
| Thu, 19 May 2022 | CHF 1.0b | CHF 1.7b | -CHF 225,735,000.00 | n/a | -4.6x | 0.6x |
| Sat, 16 Apr 2022 | CHF 1.1b | CHF 1.7b | -CHF 225,735,000.00 | n/a | -4.9x | 0.6x |
| Mon, 14 Mar 2022 | CHF 1.4b | CHF 1.6b | -CHF 160,341,000.00 | n/a | -9x | 0.9x |
| Wed, 09 Feb 2022 | CHF 2.0b | CHF 1.6b | -CHF 160,341,000.00 | n/a | -12.6x | 1.2x |
| Fri, 07 Jan 2022 | CHF 2.4b | CHF 1.6b | -CHF 160,341,000.00 | n/a | -14.7x | 1.5x |
| Sun, 05 Dec 2021 | CHF 3.2b | CHF 1.6b | -CHF 160,341,000.00 | n/a | -19.9x | 2x |
Price to Earnings Ratio
-19.9x
Current Industry PE
- There is only one company in the Swiss Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 15% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Comparison
How does Swiss Drug Retail compare with similar industries?
| CH Market | 0.96% | |
| Consumer Staples | -0.10% | |
| Food and Staples Retail | -3.37% | |
| Drug Retail | -3.64% | |
| Food Distributors | 0% | |
| Big Box Super Stores | 0% | |
| Food Retail | -1.68% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| No data available | |||||